首页> 外文期刊>International journal of colorectal disease. >Endoscopic transanal resection using the urological resectoscope in the management of patients with rectal villous adenomas.
【24h】

Endoscopic transanal resection using the urological resectoscope in the management of patients with rectal villous adenomas.

机译:内镜经肛门切除术使用泌尿外科电切镜治疗直肠绒毛状腺瘤患者。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND AND AIMS: This study reviewed the outcome of endoscopic transanal resection (ETAR) for the treatment of patients with villous rectal adenomas (VRA). PATIENTS AND METHODS: This study included 28 consecutive patients who underwent ETAR for VRA between October 1992 and December 2000. All tumors were believed to be benign (clinical examination, endorectal ultrasonography, multiples biopsies) A retrospective evaluation of the outcome of ETAR was performed. RESULTS: Thirteen patients (46.4%) had a large VRA with a tumor length of more than 5 cm. The tumor involved the anterior rectal wall in ten cases. Ten patients (35.7%) required more than one procedure. Median operating time was 35 min (range 20-50). Morbidity was 5% ( n=2); no patient died. Median postoperative stay was 3 days (range 1-5). Three patients (9.3%) were confirmed on histology as having adenocarcinoma of the rectum and underwent a conventional surgical procedure. At a median follow-up of 5 years (2.5-10.5), two recurrences were noted. CONCLUSION: Our data suggest that the technique of transanal resection has a limited but valuable place in rectal surgery. ETAR is a simple, minimally invasive, and economical method for treatment of patient with VRA. ETAR should be performed in collaboration with an experienced urological endoscopist. ETAR is a useful addition to the surgeon's armamentarium together with laser destruction and transanal endoscopic microsurgery.
机译:背景与目的:本研究回顾了内镜下经肛门切除术(ETAR)治疗绒毛性直肠腺瘤(VRA)患者的结果。患者与方法:该研究纳入了1992年10月至2000年12月间接受ETAR进行VRA治疗的28例患者。所有肿瘤均被认为是良性的(临床检查,直肠内超声,多次活检)。对ETAR的结果进行了回顾性评估。结果:十三例患者(46.4%)具有较大的VRA,肿瘤长度超过5 cm。肿瘤累及直肠前壁十例。 10名患者(35.7%)需要完成一项以上的手术。中位操作时间为35分钟(范围20-50)。发病率为5%(n = 2);没有患者死亡。术后中位停留时间为3天(范围1-5)。经组织学证实三名患者(9.3%)患有直肠腺癌,并接受了常规外科手术。中位随访期为5年(2.5-10.5),发现有两次复发。结论:我们的数据表明经肛门切除术在直肠手术中的作用有限,但有价值。 ETAR是一种用于治疗VRA的简单,微创且经济的方法。 ETAR应与经验丰富的泌尿内镜医师合作进行。 ETAR与激光破坏和经肛门内窥镜显微外科手术一起,是外科医生武器库的有用补充。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号